发明名称
摘要 <p>This invention provides a method of treating a subject afflicted with severe acute respiratory syndrome (SARS), comprising administering to the subject an amount of an interferon polypeptide effective to reduce the concentration of SARS-associated coronavirus particles in the subject, thereby treating the subject. This invention also provides methods of treating a subject infected with certain viruses and methods of reducing a subject's risk of viral infection, comprising administering to the subject an interferon polypeptide. This invention further provides a method of treating a subject afflicted with influenza or reducing a subject's risk of influenza virus infection, comprising administering to the subject an interferon polypeptide.</p>
申请公布号 JP2006526022(A) 申请公布日期 2006.11.16
申请号 JP20060514937 申请日期 2004.05.21
申请人 发明人
分类号 A61K38/21;A61P11/00;A61P31/12;A61P31/14;A61P31/16;A61P31/18;A61P31/20;A61P31/22 主分类号 A61K38/21
代理机构 代理人
主权项
地址